In hepatocellular carcinoma, ACSS3 was expressed in mitochondria and specifically recognized a subtype of hepatocellular carcinoma (namely iHCC2, which represents poor clinical survival rate)9, suggesting that the presence of ACSS3 may be noxious in hepatocellular carcinoma as well. The gene discussed is ACSS3; the disease is hepatocellular carcinoma.